Inventor · disambiguated record
Derek Maclean
Also filed as: MACLEAN DEREK
20 granted patents·14 pending applications·307 citations·filing 1995–2025
95Inventor score
Files withKAI PHARMACEUTICALS INC17AMGEN INC4APPLIED MOLECULAR TRANSPORT INC3MACLEAN DEREK3AFFYMAX INC2
Top patents by PatentIndex Score
34 records- 0195US8067532B2Modifications of peptide compositions to increase stability and delivery efficiencyMACLEAN DEREK·Filed 2008·Granted Nov 29, 2011·35 cites·17 claims
- 0293US11160869B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Nov 2, 2021·4 cites·25 claims
- 0390US11479593B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Oct 25, 2022·1 cites·30 claims
- 0490US8377880B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2012·Granted Feb 19, 2013·9 cites·2 claims
- 0590US2025034545A1Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0689US6368874B1Methods for hard-tagging an encoded synthetic libraryAFFYMAX INC·Filed 1999·Granted Apr 9, 2002·111 cites·19 claims
- 0787US9701712B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2016·Granted Jul 11, 2017·4 cites·17 claims
- 0887US5846839AMethods for hard-tagging an encoded synthetic libraryGLAXO GROUP LTD·Filed 1995·Granted Dec 8, 1998·88 cites·17 claims
- 0986US9255124B2Modifications of peptide compositions to increase stability and delivery efficiencyMACLEAN DEREK·Filed 2011·Granted Feb 9, 2016·6 cites·2 claims
- 1086US8999932B2Therapeutic agents for reducing parathyroid hormone levelsKARIM FELIX·Filed 2010·Granted Apr 7, 2015·7 cites·30 claims
- 1185US6426357B1Antagonists of follicle stimulating hormone activityAFFYMAX INC·Filed 2000·Granted Jul 30, 2002·25 cites·13 claims
- 1284US9278995B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2013·Granted Mar 8, 2016·4 cites·41 claims
- 1384US2024116983A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1483US10344765B2Stable liquid formulation of AMG 416 (etelcalcetide)AMGEN INC·Filed 2017·Granted Jul 9, 2019·2 cites·15 claims
- 1582US10077438B2Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2016·Granted Sep 18, 2018·2 cites·7 claims
- 1682US9820938B2Stable liquid formulation of AMG 416 (etelcalcetide)AMGEN INC·Filed 2014·Granted Nov 21, 2017·3 cites·15 claims
- 1782US9567370B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·2 cites·28 claims
- 1881US2022282239A1Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1979US8017583B2Methods of use of epsilon inhibitor compounds for the attenuation of painKAI PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·2 cites·18 claims
- 2076US11162500B2Stable liquid formulation of AMG 416 (etelcalcetide)AMGEN INC·Filed 2019·Granted Nov 2, 2021·0 cites·88 claims
- 2176US2025163103A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2275US8492346B2Methods of use of epsilon inhibitor compounds for the attenuation of painMACLEAN DEREK·Filed 2011·Granted Jul 23, 2013·2 cites·17 claims
- 2374US11959486B2Stable liquid formulation of AMG 416 (etelcalcetide)AMGEN INC·Filed 2021·Granted Apr 16, 2024·0 cites·13 claims
- 2474US2020399309A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2573US2020370032A1Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2670US2019194252A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2767US10280198B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2017·Granted May 7, 2019·0 cites·9 claims
- 2866US2018371448A1Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2964US2017114095A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3056US2013281380A1Methods of use of epsilon inhibitor compounds for the attenuation of painKAI PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3155US2022275029A1Compositions and particles for payload deliveryAPPLIED MOLECULAR TRANSPORT INC·Filed 2022·Application pending·0 cites
- 3249US2007141040A1Protein kinase C peptide modulators of angiogenesisCHEN LEON E·Filed 2006·Application pending·0 cites
- 3341US2011098224A1Protein kinase c peptide modulators of angiogenesisCHEN LEON E·Filed 2010·Application pending·0 cites
- 3440US2004131544A1In vivo imagingFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Derek Maclean files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →